Kidney cancer, Renal cell cancer
Results
Phase 3
This trial looked at the immunotherapy drugs ipilimumab with nivolumab or nivolumab on its own for kidney cancer.
It was for people having surgery for a type of kidney cancer called renal cell cancer. And who had a high risk of the cancer coming back.
The trial was open for people to join between 2017 and 2022. The team published results of part A in 2023.
Recruitment start: 19 December 2017
Recruitment end: 22 February 2022
Please note: In order to join a trial you will need to discuss it with your doctor, unless otherwise specified.
Dr Thomas Waddell
Bristol-Myers Squibb
Ono Pharmacutical
Last reviewed: 23 April 2024
CRUK internal database number: 16963
About Cancer generously supported by Dangoor Education since 2010. Learn more about Dangoor Education
What to ask your doctor about clinical trials.
Meet and chat to other cancer people affected by cancer.
Questions about cancer? Call freephone 0808 800 40 40 from 9 to 5 - Monday to Friday. Alternatively, you can email us.
